Globus Medical Statistics
Total Valuation
Globus Medical has a market cap or net worth of $10.76 billion. The enterprise value is $10.07 billion.
| Market Cap | 10.76B |
| Enterprise Value | 10.07B |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Globus Medical has 135.74 million shares outstanding. The number of shares has decreased by -1.66% in one year.
| Current Share Class | 113.31M |
| Shares Outstanding | 135.74M |
| Shares Change (YoY) | -1.66% |
| Shares Change (QoQ) | +1.18% |
| Owned by Insiders (%) | 17.52% |
| Owned by Institutions (%) | 83.26% |
| Float | 111.70M |
Valuation Ratios
The trailing PE ratio is 18.47 and the forward PE ratio is 16.49. Globus Medical's PEG ratio is 1.61.
| PE Ratio | 18.47 |
| Forward PE | 16.49 |
| PS Ratio | 3.47 |
| Forward PS | 3.31 |
| PB Ratio | 2.27 |
| P/TBV Ratio | 4.18 |
| P/FCF Ratio | 17.62 |
| P/OCF Ratio | 13.81 |
| PEG Ratio | 1.61 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.66, with an EV/FCF ratio of 16.50.
| EV / Earnings | 17.17 |
| EV / Sales | 3.25 |
| EV / EBITDA | 10.66 |
| EV / EBIT | 15.17 |
| EV / FCF | 16.50 |
Financial Position
The company has a current ratio of 4.56, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.56 |
| Quick Ratio | 2.83 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | 0.19 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 13.30% and return on invested capital (ROIC) is 14.16%.
| Return on Equity (ROE) | 13.30% |
| Return on Assets (ROA) | 8.18% |
| Return on Invested Capital (ROIC) | 14.16% |
| Return on Capital Employed (ROCE) | 13.39% |
| Weighted Average Cost of Capital (WACC) | 9.37% |
| Revenue Per Employee | $516,777 |
| Profits Per Employee | $97,785 |
| Employee Count | 6,000 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 1.36 |
Taxes
In the past 12 months, Globus Medical has paid $71.77 million in taxes.
| Income Tax | 71.77M |
| Effective Tax Rate | 10.90% |
Stock Price Statistics
The stock price has increased by +36.28% in the last 52 weeks. The beta is 0.95, so Globus Medical's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +36.28% |
| 50-Day Moving Average | 84.97 |
| 200-Day Moving Average | 80.90 |
| Relative Strength Index (RSI) | 46.20 |
| Average Volume (20 Days) | 1,795,724 |
Short Selling Information
The latest short interest is 3.92 million, so 2.89% of the outstanding shares have been sold short.
| Short Interest | 3.92M |
| Short Previous Month | 3.12M |
| Short % of Shares Out | 2.89% |
| Short % of Float | 3.51% |
| Short Ratio (days to cover) | 1.98 |
Income Statement
In the last 12 months, Globus Medical had revenue of $3.10 billion and earned $586.71 million in profits. Earnings per share was $4.29.
| Revenue | 3.10B |
| Gross Profit | 2.12B |
| Operating Income | 663.99M |
| Pretax Income | 658.47M |
| Net Income | 586.71M |
| EBITDA | 945.06M |
| EBIT | 663.99M |
| Earnings Per Share (EPS) | $4.29 |
Balance Sheet
The company has $629.85 million in cash and $115.94 million in debt, with a net cash position of $683.35 million or $5.03 per share.
| Cash & Cash Equivalents | 629.85M |
| Total Debt | 115.94M |
| Net Cash | 683.35M |
| Net Cash Per Share | $5.03 |
| Equity (Book Value) | 4.73B |
| Book Value Per Share | 34.88 |
| Working Capital | 1.72B |
Cash Flow
In the last 12 months, operating cash flow was $778.51 million and capital expenditures -$168.19 million, giving a free cash flow of $610.32 million.
| Operating Cash Flow | 778.51M |
| Capital Expenditures | -168.19M |
| Depreciation & Amortization | 281.07M |
| Net Borrowing | n/a |
| Free Cash Flow | 610.32M |
| FCF Per Share | $4.50 |
Margins
Gross margin is 68.49%, with operating and profit margins of 21.41% and 18.92%.
| Gross Margin | 68.49% |
| Operating Margin | 21.41% |
| Pretax Margin | 21.24% |
| Profit Margin | 18.92% |
| EBITDA Margin | 30.48% |
| EBIT Margin | 21.41% |
| FCF Margin | 19.68% |
Dividends & Yields
Globus Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.66% |
| Shareholder Yield | 1.66% |
| Earnings Yield | 5.46% |
| FCF Yield | 5.67% |
Analyst Forecast
The average price target for Globus Medical is $108.64, which is 37.12% higher than the current price. The consensus rating is "Buy".
| Price Target | $108.64 |
| Price Target Difference | 37.12% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 7.29% |
| EPS Growth Forecast (3Y) | 12.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Globus Medical has an Altman Z-Score of 9.96 and a Piotroski F-Score of 7.
| Altman Z-Score | 9.96 |
| Piotroski F-Score | 7 |